← TruNorth

Cartesian Therapeutics vs Celldex Therapeutics

On overall TruNorth grade, Celldex Therapeutics scores higher (Cartesian Therapeutics: C, Celldex Therapeutics: A). Both graded from public records across nine values categories.

C
Cartesian Therapeutics
55.1/100
A
Celldex Therapeutics
71.8/100

Political donations

Cartesian Therapeutics

FEC: $284K in executive political donations; partisan lean Democratic +23 across 13 executive donors.

Celldex Therapeutics

FEC: $261K in executive political donations; partisan lean split across 10 executive donors.

Environment

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

Labor

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

DEI

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

EEO-1 workforce demographics on federal record (FY2018, DOL OFCCP FOIA release): 136 US employees — 57.4% women, 16.9% racial/ethnic minorities; management 44.6% women, 12.5% minorities.

Charity

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

Animal testing

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

Firearms

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

Privacy

Cartesian Therapeutics

No public record found.

Celldex Therapeutics

No public record found.

Executive pay

Cartesian Therapeutics

CEO total compensation $7.3M (2024; other named executives averaged $2.8M) — SEC pay-versus-performance disclosure (Item 402(v) XBRL).

Celldex Therapeutics

CEO-to-median-worker pay ratio 23:1 (median employee pay $235,733) — SEC proxy statement (DEF 14A, 2026).

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →